REGENERON PHARMACEUTICALS INC.

Company

REGENERON PHARMACEUTICALS, INC.

Filed

March 31, 2003

Period of Report

December 31, 2002

Accession Number

0000950123-03-003582

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →